BioSpace News Archive

Alz1, a brand of Igea Pharma (IGPH:SIX Swiss Ex) focused on reinventing proactive healthcare in Alzheimer’s disease, today announced the launch of Alz1, the first solution designed to detect and reduce high free copper levels in the bloodstream — a risk factor associated with Alzheimer’s disease — through a first-of-its-kind in-home blood test and dietary supplement for those with elevated free copper levels

Offers Interactive First Aid Systems to Help Bystanders Save Lives

hēRo3 lets users build cost-effectiveness models in substantially less time than required when using spreadsheet software.

The Jim Rutt Show with guest Cory Doctorow

Pixel by LabCorp Now Available with Phlebotomy Collection Through LabCorp’s Nationwide Patient Service Center Network

CMS Imaging, Inc is proud to announce the first clinical installation in the United States of the Intelli-C at ImageCare, LLC.

The newly constructed state-of-art production facility is operated by the Liaoning Yisheng Biopharma subsidiary.

Enrollment Completed Ahead of Schedule CytRx Eligible to Receive up to $120 Million in Future Milestones, Plus Royalties, From Arimoclomol Licensing Agreement

The U.S. FDA Orphan Drug program provides orphan designation to novel drugs that are intended for the treatment of rare diseases

The global bronchiectasis drugs market is expected to post a CAGR close to 5% during the period 2019-2023, according to the latest market research report by Technavio.